What is important, we observed dramatic induction of AXL expression in SH-SY5Y cells by HDAC class I inhibitor, which could be beneficial for the simultaneous repression of AXL and HDAC, as it was described for glioma [53]. Here, AXL is linked to central nervous system cancer.